Amgen is a leading biopharmaceutical company that develops innovative medicines in areas with significant unmet needs. Read ...

Jefferies analysts singled out the stocks that will be affected the most and the least by potential import taxes.

Companies are leaning into new U.S. factories, while capital is starting to look elsewhere, Ludovic Subran writes in a guest ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.

Amgen is lagging behind rivals like Novo Nordisk ... will drive its obesity sales to $3.7 billion in 2025 once initial manufacturing problems are resolved. The market looks set to have a new ...

The companies updated their partnership agreement in 2020, with AstraZeneca overseeing the drug's general development and Amgen leading manufacturing, sharing expenses and profits equally.

The initiative aims to accelerate employee onboarding, improve retention, and introduce tech-driven training methods.

The case had been filed last year by Amgen after the state Prescription Drug Affordability Board determined that its big-selling medication called Enbrel is unaffordable and began a process to ...